| CERE Shares Outstanding History Table | ||||||||||||||||||||
Below is a table of the CERE shares outstanding history going back to 2/18/2022:
Also see: CERE Market Cap History CERE YTD Return |
CERE Shares Outstanding History — Cerevel Therapeutics Holdings Share Count Over Time
As of 3/31/2024 Cerevel Therapeutics Holdings has 181.89 million CERE shares outstanding. Investors often track the CERE shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows CERE share count trends over time, with 9 historical shares outstanding datapoints presented, dating back to 2/18/2022.
| CERE Shares Outstanding History Chart | |||||||||||||||||||||
CERE Historical Shares Outstanding: +10.25% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||
| CERE Stock Price Chart |
| About Cerevel Therapeutics Holdings Inc |
| Cerevel Therapeutics Holdings is a clinical-stage biopharmaceutical company. Co.'s programs: Emraclidine is a positive allosteric modulator (PAM), that selectively targets the muscarinic acetylcholine 4 receptor subtype; Darigabat, which is a PAM that selectively targets the alpha-2/3/5 subunits of the GABAA receptor; Tavapadon, which is a selective dopamine D1/D5 receptor partial agonist that it is developing for the treatment of early- and late-stage Parkinson's disease; and CVL-871, which is a selective dopamine D1/D5 receptor partial agonist specifically designed to achieve a level of partial agonism. We show 9 historical shares outstanding datapoints in our coverage of CERE's shares outstanding history. Understanding the changing numbers of CERE shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like CERE versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching CERE by allowing them to research CERE shares outstanding history as well as any other stock in our coverage universe. |
| CERE Current Stock Quote |
Quotes delayed 20 minutes  Free CERE Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| CERE Share Performance |
| Shares Outstanding Peers |
| Cerevel Therapeutics Holdings (CERE) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
CERS Shares Outstanding History CFMS Shares Outstanding History CFRX Shares Outstanding History CGEM Shares Outstanding History CGEN Shares Outstanding History CGIX Shares Outstanding History CGNT Shares Outstanding History CGON Shares Outstanding History CGTX Shares Outstanding History CHE Shares Outstanding History More Healthcare companies » |
CERE Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
